Expand VERA Menu
VERA MENU

VERA Stock Posts


Upcoming Earnings

VERA Vera Therapeutics - Class A31.51-0.46 (-1.4%)

Vera Therapeutics - Class A will report earnings after the market closes. View Calendar The market is expecting a ±10.1% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±2.2%. View Expected Move (Conf Call: Nov 5 4:30 PM)
Unusual Option Volume

VERA Vera Therapeutics - Class A29.68+0.76 (+2.6%)

Vera Therapeutics - Class A trades 1,342 contracts. VERA will report earnings on Nov 5, 2026. The company has the following event: ASN Kidney Week on Oct 22, 2026. News: Vera Therapeutics to Host ASN Kidney Week Investor Webcast and Third Quarter 2026 Financial Results Conference Webcast
Unusual Option Volume

VERA Vera Therapeutics - Class A29.46-0.37 (-1.2%)

Vera Therapeutics - Class A trades 5,148 contracts. The highest volume is in the 15-Jan-27 30 puts, which is -1.8% below the current price.
Unusual Option Volume

VERA Vera Therapeutics - Class A34.33+2.56 (+8.1%)

Vera Therapeutics - Class A trades 1,069 contracts.
Unusual Option Volume

VERA Vera Therapeutics - Class A33.16-0.89 (-2.6%)

Vera Therapeutics - Class A trades 1,974 contracts. The company has the following event: Morgan Stanley 24th Annual Global Healthcare Conference on Sep 15, 2026. News: Vera Therapeutics Announces TRUTAKNA (atacicept-vymj) Stabilized eGFR and Prevented Kidney Disease Progression Through Two Years in ORIGIN 3 Final Efficacy Analysis in IgA Nephropathy
Top Implied #Volatility Gainers VERA WMB $XPEV
Market Data Delayed 15 Minutes